♥
ISIN : INE070I01018
NSE : INSECTICID
BSE : 532851
Face Value : 10
Industry : Pesticides & Agrochemicals
EPS : 34.59
EPS (TTM) : 41.29
Price to Earning (P/E) : 17.08
Book Value : 342.44
Price to Bookvalue (P/B) : 1.73
Dividend Yield : 0 %
Return on Equity (ROE) : 10.60 %
Return on Capital Employed (ROCE) : 13.16 %
Insecticides (India) Limited
ISIN : INE070I01018
NSE : INSECTICID
BSE : 532851
Face Value : 10
Industry : Pesticides & Agrochemicals
EPS : 34.59
EPS (TTM) : 41.29
Price to Earning (P/E) : 17.08
Book Value : 342.44
Price to Bookvalue (P/B) : 1.73
Dividend Yield : 0 %
Return on Equity (ROE) : 10.60 %
Return on Capital Employed (ROCE) : 13.16 %
Insecticides (India) share price(02-Apr-2026) | |
|---|---|
| Open / Close | 0 - 0 NAN % |
| Low / High | 0 - 0 NAN % |
| Trade Volume | 0 |
| 52 Week Low / High | 0 - 0 NAN % |
| Open / Close | 565.2 - 607.25 7.4 % |
| Low / High | 565.2 - 610 7.9 % |
| Trade Volume | 1,518 |
| 52 Week Low / High | 525.9 - 1096.3 108.5 % |
-
YOU MAY ALSO LIKE
- Stock market course tutorial
Stock Market Investment Course explained in simple words. - High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE - Share Market basics for beginners
Share Market jargons in simple terms - Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE - How much money do you need to retire
Know how much money do you need to retire, before how much to invest ? - CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator
CONSOLIDATED QUARTERLY RESULT FOR INSECTICIDES (INDIA) LIMITED
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 2779.8 | 5606.9 | 5822.09 | 3565.32 | 3018.97 | 6399.53 | 6959.88 | 3579.42 | 2725.02 | 6566.85 |
| Total Income | 2800.67 | 5608.84 | 5824.93 | 3569.07 | 3023.09 | 6438.41 | 6958.14 | 3591.62 | 2770.37 | 6592.01 |
| Total Expenditure | 2441.36 | 5022.37 | 5137.55 | 3332.76 | 3301.75 | 5943.06 | 6140.56 | 3319.32 | 2635.43 | 5851.82 |
| Other Income | 20.87 | 1.94 | 2.84 | 3.74 | 4.12 | 38.87 | -1.74 | 12.19 | 45.35 | 25.15 |
| Operating Profit | 359.31 | 586.47 | 687.38 | 236.31 | -278.66 | 495.35 | 817.58 | 272.3 | 134.94 | 740.19 |
| Interest | 10.6 | 14.08 | 27.4 | 48.38 | 44.66 | 31.66 | 28.61 | 27.87 | 20.74 | 16.32 |
| PBDT | 348.71 | 572.39 | 659.98 | 187.93 | -323.32 | 463.69 | 788.97 | 244.43 | 114.2 | 723.87 |
| Depreciation | 67.77 | 66.24 | 63.99 | 64.32 | 66.47 | 68.81 | 73.51 | 74.18 | 76 | 71.33 |
| Profit Before Tax | 280.94 | 506.15 | 595.99 | 123.61 | -389.79 | 394.88 | 715.46 | 170.25 | 38.2 | 652.54 |
| Tax | 57.03 | 126.19 | 149.36 | 30.84 | -100.21 | 104.58 | 185.97 | 47.68 | -39.97 | 164.17 |
| Profit After Tax | 223.91 | 379.96 | 446.63 | 92.77 | -289.58 | 290.3 | 529.49 | 122.57 | 78.17 | 488.37 |
| Net Profit | 223.91 | 379.96 | 446.63 | 92.77 | -289.58 | 290.3 | 529.49 | 122.57 | 78.17 | 488.37 |
| Equity Capital | 197.32 | 197.32 | 197.32 | 295.98 | 295.98 | 295.98 | 295.98 | 295.98 | 295.98 | 295.98 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | 11.32 | 19.41 | 22.72 | 3.16 | -9.9 | 9.85 | 17.96 | 4.16 | 2.62 | 16.56 |
| Diluted Eps After Extraordinary Items | 11.32 | 19.41 | 15.15 | 3.16 | -9.9 | 9.85 | 17.95 | 4.16 | 2.62 | 16.56 |
| Diluted Eps Before Extraordinary Items | 11.32 | 19.41 | 15.15 | 3.16 | -9.9 | 9.85 | 17.95 | 4.16 | 2.62 | 16.56 |
STANDALONE QUARTERLY RESULT FOR INSECTICIDES (INDIA) LIMITED
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 2779.8 | 5606.9 | 5822.09 | 3565.32 | 3018.97 | 6399.53 | 6959.88 | 3579.42 | 2725.02 | 6566.85 |
| Total Income | 2800.67 | 5608.84 | 5824.93 | 3569.07 | 3023.09 | 6438.41 | 6958.14 | 3591.77 | 2770.6 | 6592.24 |
| Total Expenditure | 2441.36 | 5022.37 | 5137.53 | 3332.2 | 3302.24 | 5943.05 | 6137.04 | 3319.32 | 2632.42 | 5848.56 |
| Other Income | 20.87 | 1.94 | 2.84 | 3.74 | 4.12 | 38.87 | -1.74 | 12.35 | 45.58 | 25.39 |
| Operating Profit | 359.31 | 586.47 | 687.4 | 236.87 | -279.15 | 495.36 | 821.1 | 272.45 | 138.18 | 743.68 |
| Interest | 10.6 | 14.08 | 27.4 | 48.38 | 44.66 | 31.66 | 28.61 | 27.87 | 20.7 | 16.25 |
| PBDT | 348.71 | 572.39 | 660 | 188.49 | -323.81 | 463.7 | 792.49 | 244.58 | 117.48 | 727.43 |
| Depreciation | 67.77 | 66.24 | 63.99 | 64.32 | 66.47 | 68.81 | 73.51 | 74.18 | 75.98 | 71.3 |
| Profit Before Tax | 280.94 | 506.15 | 596.01 | 124.17 | -390.28 | 394.89 | 718.98 | 170.4 | 41.5 | 656.13 |
| Tax | 57.03 | 126.19 | 149.36 | 30.84 | -100.19 | 104.58 | 186.58 | 47.68 | -39.29 | 164.78 |
| Profit After Tax | 223.91 | 379.96 | 446.65 | 93.33 | -290.09 | 290.31 | 532.4 | 122.72 | 80.79 | 491.35 |
| Net Profit | 223.91 | 379.96 | 446.65 | 93.33 | -290.09 | 290.31 | 532.4 | 122.72 | 80.79 | 491.35 |
| Equity Capital | 197.32 | 197.32 | 197.32 | 295.98 | 295.98 | 295.98 | 295.98 | 295.98 | 295.98 | 295.98 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | 11.35 | 19.26 | 22.64 | 3.15 | -9.8 | 9.81 | 17.99 | 4.15 | 2.73 | 16.6 |
| Diluted Eps After Extraordinary Items | 11.35 | 19.26 | 15.09 | 3.15 | -9.8 | 9.81 | 17.99 | 4.14 | 2.73 | 16.6 |
| Diluted Eps Before Extraordinary Items | 11.35 | 19.26 | 15.09 | 3.15 | -9.8 | 9.81 | 17.99 | 4.14 | 2.73 | 16.6 |
CONSOLIDATED ANNUAL RESULT FOR INSECTICIDES (INDIA) LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 15039.6 | 18013.3 | 19663.9 |
| Total Income | 15082.3 | 18025.9 | 19758.5 |
| Total Expenditure | 13342.8 | 16794.4 | 18038.3 |
| Other Income | 42.72 | 12.64 | 94.68 |
| Operating Profit | 1739.48 | 1231.49 | 1720.2 |
| Interest | 66.34 | 134.51 | 108.88 |
| PBDT | 1673.14 | 1096.98 | 1611.32 |
| Depreciation | 263.49 | 261.02 | 292.5 |
| Profit Before Tax | 1409.65 | 835.96 | 1318.82 |
| Tax | 339.44 | 206.18 | 298.26 |
| Profit After Tax | 1070.21 | 629.78 | 1020.56 |
| Net Profit | 1070.21 | 629.78 | 1020.56 |
| Equity Capital | 197.32 | 295.98 | 295.98 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 9839.36 | ||
| Calculated EPS | 54.44 | 21.36 | 34.59 |
| Diluted Eps After Extraordinary Items | 54.17 | 21.36 | 34.59 |
| Diluted Eps Before Extraordinary Items | 54.17 | 21.36 | 34.59 |
STANDALONE ANNUAL RESULT FOR INSECTICIDES (INDIA) LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 15039.6 | 18013.3 | 19663.9 |
| Total Income | 15082.3 | 18025.9 | 19758.9 |
| Total Expenditure | 13342.8 | 16794.3 | 18031.8 |
| Other Income | 42.72 | 12.64 | 95.07 |
| Operating Profit | 1739.48 | 1231.59 | 1727.12 |
| Interest | 66.34 | 134.51 | 108.84 |
| PBDT | 1673.14 | 1097.08 | 1618.28 |
| Depreciation | 263.49 | 261.02 | 292.48 |
| Profit Before Tax | 1409.65 | 836.06 | 1325.8 |
| Tax | 339.44 | 206.2 | 299.54 |
| Profit After Tax | 1070.21 | 629.86 | 1026.26 |
| Net Profit | 1070.21 | 629.86 | 1026.26 |
| Equity Capital | 197.32 | 295.98 | 295.98 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 9815.06 | ||
| Calculated EPS | 54.24 | 21.28 | 34.67 |
| Diluted Eps After Extraordinary Items | 53.97 | 21.28 | 34.67 |
| Diluted Eps Before Extraordinary Items | 53.97 | 21.28 | 34.67 |
CONSOLIDATED PROFIT / LOSS FOR INSECTICIDES (INDIA) LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 1586.56 Cr | 1651.1 Cr | 1985.36 Cr | 2195.26 Cr |
| Sales | 1578.44 Cr | 1645.39 Cr | 1981.33 Cr | 2185.26 Cr |
| Job Work/ Contract Receipts | 36.46 Lk | 11.79 Lk | 0 | 0 |
| Net Sales | 1420.23 Cr | 1503.96 Cr | 1801.33 Cr | 1966.39 Cr |
| Increase/Decrease in Stock | -35.26 Cr | 10.1 Cr | -125.97 Cr | -26.07 Cr |
| Raw Material Consumed | 1009.49 Cr | 997.28 Cr | 1400.91 Cr | 1361.85 Cr |
| Opening Raw Materials | 170.34 Cr | 273.6 Cr | 254.05 Cr | 355.61 Cr |
| Purchases Raw Materials | 1054.8 Cr | 916.87 Cr | 1390.34 Cr | 1124.12 Cr |
| Closing Raw Materials | 273.6 Cr | 254.05 Cr | 355.61 Cr | 276.73 Cr |
| Other Direct Purchases / Brought in cost | 57.95 Cr | 60.86 Cr | 112.12 Cr | 158.86 Cr |
| Power & Fuel Cost | 22.43 Cr | 30.3 Cr | 36.08 Cr | 44.91 Cr |
| Electricity & Power | 22.43 Cr | 30.3 Cr | 36.08 Cr | 44.91 Cr |
| Employee Cost | 76.51 Cr | 86.65 Cr | 98.38 Cr | 117.33 Cr |
| Salaries, Wages & Bonus | 67.92 Cr | 76.52 Cr | 86.95 Cr | 104.83 Cr |
| Contributions to EPF & Pension Funds | 3.88 Cr | 4.41 Cr | 5.1 Cr | 5.76 Cr |
| Workmen and Staff Welfare Expenses | 3.65 Cr | 4.35 Cr | 4.93 Cr | 5.14 Cr |
| Other Manufacturing Expenses | 148.02 Cr | 157.55 Cr | 181.88 Cr | 212.66 Cr |
| Repairs and Maintenance | 4.49 Cr | 5.69 Cr | 7.69 Cr | 11.45 Cr |
| Packing Material Consumed | 93.64 Cr | 100.12 Cr | 110.68 Cr | 129.2 Cr |
| General and Administration Expenses | 20.69 Cr | 25.4 Cr | 31.41 Cr | 40.7 Cr |
| Rent , Rates & Taxes | 53.6 Lk | 72.57 Lk | 97.02 Lk | 1.43 Cr |
| Insurance | 2.76 Cr | 2.67 Cr | 3.23 Cr | 4.39 Cr |
| Printing and stationery | 21.44 Lk | 25.73 Lk | 32.31 Lk | 34.27 Lk |
| Professional and legal fees | 4.3 Cr | 5.46 Cr | 6.43 Cr | 9.01 Cr |
| Traveling and conveyance | 10.94 Cr | 14.24 Cr | 18.12 Cr | 22.78 Cr |
| Selling and Distribution Expenses | 11.78 Cr | 15.14 Cr | 38.01 Cr | 42.42 Cr |
| Advertisement & Sales Promotion | 5.25 Cr | 4.67 Cr | 28.87 Cr | 31.48 Cr |
| Sales Commissions & Incentives | 6.53 Cr | 6.14 Cr | 6.82 Cr | 7.74 Cr |
| Miscellaneous Expenses | 14.24 Cr | 11.87 Cr | 18.74 Cr | 10.03 Cr |
| Bad debts /advances written off | 47.06 Lk | 1.4 Cr | 26.71 Lk | 22.76 Lk |
| Provision for doubtful debts | 3.49 Cr | 3.6 Cr | 25.34 Lk | 2.72 Cr |
| Loss on disposal of fixed assets(net) | 37.94 Lk | 1.29 Cr | 6.65 Lk | 0 |
| Loss on foreign exchange fluctuations | 0 | 0 | 10.6 Cr | 0 |
| Total Expenditure | 1267.89 Cr | 1334.28 Cr | 1679.44 Cr | 1803.83 Cr |
| Other Income | 7.73 Cr | 4.27 Cr | 1.26 Cr | 9.47 Cr |
| Interest Received | 2.51 Cr | 48.58 Lk | 11.83 Lk | 2.35 Cr |
| Dividend Received | 9.62 Lk | 10.22 Lk | 20.31 Lk | 22.05 Lk |
| Profit on sale of Fixed Assets | 0 | 0 | 0 | 1.73 Cr |
| Provision Written Back | 0 | 0 | 0 | 33.5 Lk |
| Foreign Exchange Gains | 4.36 Cr | 1.7 Cr | 0 | 3.97 Cr |
| Operating Profit | 160.06 Cr | 173.95 Cr | 123.15 Cr | 172.02 Cr |
| Interest | 6.65 Cr | 6.63 Cr | 13.45 Cr | 10.89 Cr |
| Interest on Term Loan | 30.65 Lk | 33 Lk | 35.21 Lk | 3.56 Cr |
| Bank Charges etc | 2.73 Cr | 1.66 Cr | 2.17 Cr | 1.69 Cr |
| PBDT | 153.41 Cr | 167.31 Cr | 109.7 Cr | 161.13 Cr |
| Depreciation | 24.67 Cr | 26.35 Cr | 26.1 Cr | 29.25 Cr |
| Profit Before Taxation & Exceptional Items | 128.74 Cr | 140.96 Cr | 83.6 Cr | 131.88 Cr |
| Exceptional Income / Expenses | -9.7 Cr | 0 | 0 | 0 |
| Profit Before Tax | 119.03 Cr | 141.37 Cr | 83.83 Cr | 132.19 Cr |
| Provision for Tax | 25.6 Cr | 33.94 Cr | 20.62 Cr | 29.83 Cr |
| Current Income Tax | 31.53 Cr | 36.02 Cr | 21.23 Cr | 34.29 Cr |
| Deferred Tax | -4.91 Cr | -85.69 Lk | -21.06 Lk | -3.13 Cr |
| Profit After Tax | 93.43 Cr | 107.43 Cr | 63.21 Cr | 102.36 Cr |
| Share of Associate | 47 Lk | 0 | 0 | 0 |
| Consolidated Net Profit | 93.9 Cr | 107.43 Cr | 63.21 Cr | 102.36 Cr |
| Profit Balance B/F | 575.47 Cr | 663.22 Cr | 770.43 Cr | 818.26 Cr |
| Appropriations | 669.37 Cr | 770.65 Cr | 833.64 Cr | 920.62 Cr |
| Other Appropriation | 2.02 Cr | 21.28 Lk | 6.51 Cr | -6.22 Lk |
| Equity Dividend % | 20 | 30 | 30 | 30 |
| Earnings Per Share | 45.43 | 54.44 | 21.36 | 34.59 |
| Adjusted EPS | 45.43 | 54.44 | 21.36 | 34.59 |
STANDALONE PROFIT / LOSS FOR INSECTICIDES (INDIA) LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 1586.56 Cr | 1651.1 Cr | 1985.36 Cr | 2195.26 Cr |
| Sales | 1578.44 Cr | 1645.39 Cr | 1981.33 Cr | 2185.26 Cr |
| Job Work/ Contract Receipts | 36.46 Lk | 11.79 Lk | 0 | 0 |
| Net Sales | 1420.23 Cr | 1503.96 Cr | 1801.33 Cr | 1966.39 Cr |
| Increase/Decrease in Stock | -35.26 Cr | 10.1 Cr | -125.97 Cr | -26.02 Cr |
| Raw Material Consumed | 1009.49 Cr | 997.28 Cr | 1400.91 Cr | 1361.88 Cr |
| Opening Raw Materials | 170.34 Cr | 273.6 Cr | 254.05 Cr | 355.61 Cr |
| Purchases Raw Materials | 1054.8 Cr | 916.87 Cr | 1390.34 Cr | 1123.69 Cr |
| Closing Raw Materials | 273.6 Cr | 254.05 Cr | 355.61 Cr | 276.27 Cr |
| Other Direct Purchases / Brought in cost | 57.95 Cr | 60.86 Cr | 112.12 Cr | 158.86 Cr |
| Power & Fuel Cost | 22.43 Cr | 30.3 Cr | 36.08 Cr | 44.9 Cr |
| Electricity & Power | 22.43 Cr | 30.3 Cr | 36.08 Cr | 44.9 Cr |
| Employee Cost | 76.51 Cr | 86.65 Cr | 98.38 Cr | 117.22 Cr |
| Salaries, Wages & Bonus | 67.92 Cr | 76.52 Cr | 86.95 Cr | 104.73 Cr |
| Contributions to EPF & Pension Funds | 3.88 Cr | 4.41 Cr | 5.1 Cr | 5.75 Cr |
| Workmen and Staff Welfare Expenses | 3.65 Cr | 4.35 Cr | 4.93 Cr | 5.14 Cr |
| Other Manufacturing Expenses | 148.02 Cr | 157.55 Cr | 181.88 Cr | 212.09 Cr |
| Repairs and Maintenance | 4.49 Cr | 5.69 Cr | 7.69 Cr | 11.45 Cr |
| Packing Material Consumed | 93.64 Cr | 100.12 Cr | 110.68 Cr | 129.17 Cr |
| General and Administration Expenses | 20.69 Cr | 25.4 Cr | 31.4 Cr | 40.68 Cr |
| Rent , Rates & Taxes | 53.6 Lk | 72.57 Lk | 96.78 Lk | 1.43 Cr |
| Insurance | 2.76 Cr | 2.67 Cr | 3.23 Cr | 4.39 Cr |
| Printing and stationery | 21.44 Lk | 25.73 Lk | 32.31 Lk | 34.22 Lk |
| Professional and legal fees | 4.3 Cr | 5.46 Cr | 6.42 Cr | 9 Cr |
| Traveling and conveyance | 10.94 Cr | 14.24 Cr | 18.12 Cr | 22.77 Cr |
| Selling and Distribution Expenses | 11.78 Cr | 15.14 Cr | 38.01 Cr | 42.42 Cr |
| Advertisement & Sales Promotion | 5.25 Cr | 4.67 Cr | 28.87 Cr | 31.48 Cr |
| Sales Commissions & Incentives | 6.53 Cr | 6.14 Cr | 6.82 Cr | 7.74 Cr |
| Miscellaneous Expenses | 14.24 Cr | 11.87 Cr | 18.74 Cr | 10.02 Cr |
| Bad debts /advances written off | 47.06 Lk | 1.4 Cr | 26.71 Lk | 22.76 Lk |
| Provision for doubtful debts | 3.49 Cr | 3.6 Cr | 25.34 Lk | 2.72 Cr |
| Loss on disposal of fixed assets(net) | 37.94 Lk | 1.29 Cr | 6.65 Lk | 0 |
| Loss on foreign exchange fluctuations | 0 | 0 | 10.6 Cr | 0 |
| Total Expenditure | 1267.89 Cr | 1334.28 Cr | 1679.43 Cr | 1803.18 Cr |
| Other Income | 7.73 Cr | 4.27 Cr | 1.26 Cr | 9.51 Cr |
| Interest Received | 2.51 Cr | 48.58 Lk | 11.83 Lk | 2.35 Cr |
| Dividend Received | 9.62 Lk | 10.22 Lk | 20.31 Lk | 22.05 Lk |
| Profit on sale of Fixed Assets | 0 | 0 | 0 | 1.73 Cr |
| Provision Written Back | 0 | 0 | 0 | 33.5 Lk |
| Foreign Exchange Gains | 4.36 Cr | 1.7 Cr | 0 | 3.97 Cr |
| Operating Profit | 160.06 Cr | 173.95 Cr | 123.16 Cr | 172.71 Cr |
| Interest | 6.65 Cr | 6.63 Cr | 13.45 Cr | 10.88 Cr |
| Interest on Term Loan | 30.65 Lk | 33 Lk | 35.21 Lk | 3.56 Cr |
| Bank Charges etc | 2.73 Cr | 1.66 Cr | 2.17 Cr | 1.69 Cr |
| PBDT | 153.41 Cr | 167.31 Cr | 109.71 Cr | 161.83 Cr |
| Depreciation | 24.67 Cr | 26.35 Cr | 26.1 Cr | 29.25 Cr |
| Profit Before Taxation & Exceptional Items | 128.74 Cr | 140.96 Cr | 83.61 Cr | 132.58 Cr |
| Exceptional Income / Expenses | -9.7 Cr | 0 | 0 | 0 |
| Profit Before Tax | 119.03 Cr | 140.96 Cr | 83.61 Cr | 132.58 Cr |
| Provision for Tax | 25.6 Cr | 33.94 Cr | 20.62 Cr | 29.95 Cr |
| Current Income Tax | 31.53 Cr | 36.02 Cr | 21.23 Cr | 34.29 Cr |
| Deferred Tax | -4.91 Cr | -85.69 Lk | -20.89 Lk | -3 Cr |
| Profit After Tax | 93.43 Cr | 107.02 Cr | 62.99 Cr | 102.62 Cr |
| Consolidated Net Profit | 93.43 Cr | 107.02 Cr | 62.99 Cr | 102.62 Cr |
| Profit Balance B/F | 573.98 Cr | 661.24 Cr | 768.04 Cr | 815.66 Cr |
| Appropriations | 667.41 Cr | 768.26 Cr | 831.02 Cr | 918.28 Cr |
| Other Appropriation | 2.03 Cr | 22.75 Lk | 6.49 Cr | 2.65 Lk |
| Equity Dividend % | 20 | 30 | 30 | 30 |
| Earnings Per Share | 45.21 | 54.24 | 21.28 | 34.67 |
| Adjusted EPS | 45.21 | 54.24 | 21.28 | 34.67 |
CONSOLIDATED CASH FLOW FOR INSECTICIDES (INDIA) LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 119.5 Cr | 141.37 Cr | 83.83 Cr | 132.19 Cr |
| Adjustment | 29.41 Cr | 36.05 Cr | 37.49 Cr | 38.99 Cr |
| Changes In working Capital | 33.7 Cr | -2.01 Cr | -101.32 Cr | 25.99 Cr |
| Cash Flow after changes in Working Capital | 182.62 Cr | 175.41 Cr | 20 Cr | 197.17 Cr |
| Cash Flow from Operating Activities | 155.36 Cr | 134.85 Cr | -10.63 Cr | 183.67 Cr |
| Cash Flow from Investing Activities | -112.6 Cr | 9.31 Cr | -86.4 Cr | -42.99 Cr |
| Cash Flow from Financing Activitie | -104.03 Cr | -114.64 Cr | 79.68 Cr | -98.06 Cr |
| Net Cash Inflow / Outflow | -61.27 Cr | 29.52 Cr | -17.35 Cr | 42.62 Cr |
| Opening Cash & Cash Equivalents | 67.73 Cr | 6.46 Cr | 35.98 Cr | 18.63 Cr |
| Closing Cash & Cash Equivalent | 6.46 Cr | 35.98 Cr | 18.63 Cr | 61.25 Cr |
STANDALONE CASH FLOW FOR INSECTICIDES (INDIA) LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 119.03 Cr | 140.96 Cr | 83.61 Cr | 132.58 Cr |
| Adjustment | 29.88 Cr | 36.46 Cr | 37.72 Cr | 39.29 Cr |
| Changes In working Capital | 33.7 Cr | -2.01 Cr | -101.32 Cr | 26.18 Cr |
| Cash Flow after changes in Working Capital | 182.62 Cr | 175.41 Cr | 20.01 Cr | 198.06 Cr |
| Cash Flow from Operating Activities | 155.36 Cr | 134.85 Cr | -10.62 Cr | 184.55 Cr |
| Cash Flow from Investing Activities | -112.6 Cr | 9.31 Cr | -86.71 Cr | -43.83 Cr |
| Cash Flow from Financing Activitie | -104.03 Cr | -114.64 Cr | 79.73 Cr | -98.05 Cr |
| Net Cash Inflow / Outflow | -61.27 Cr | 29.52 Cr | -17.6 Cr | 42.67 Cr |
| Opening Cash & Cash Equivalents | 67.73 Cr | 6.46 Cr | 35.98 Cr | 18.38 Cr |
| Closing Cash & Cash Equivalent | 6.46 Cr | 35.98 Cr | 18.38 Cr | 61.05 Cr |
CONSOLIDATED BALANCE SHEET FOR INSECTICIDES (INDIA) LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 20.67 Cr | 19.73 Cr | 29.6 Cr | 29.6 Cr |
| Equity - Authorised | 25 Cr | 25 Cr | 35 Cr | 35 Cr |
| Equity - Issued | 20.67 Cr | 19.73 Cr | 29.6 Cr | 29.6 Cr |
| Equity Paid Up | 20.67 Cr | 19.73 Cr | 29.6 Cr | 29.6 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 799.71 Cr | 849.88 Cr | 888.69 Cr | 983.94 Cr |
| Securities Premium | 104.1 Cr | 45.84 Cr | 35.98 Cr | 35.98 Cr |
| Profit & Loss Account Balance | 663.22 Cr | 770.43 Cr | 818.26 Cr | 911.81 Cr |
| General Reserves | 32.02 Cr | 31.08 Cr | 31.08 Cr | 31.08 Cr |
| Reserve excluding Revaluation Reserve | 799.71 Cr | 849.88 Cr | 888.69 Cr | 983.94 Cr |
| Shareholder's Funds | 820.38 Cr | 869.61 Cr | 918.29 Cr | 1013.53 Cr |
| Secured Loans | 2.4 Cr | 1.85 Cr | 1.86 Cr | 29.17 Cr |
| Term Loans - Banks | 0 | 0 | 0 | 34.42 Cr |
| Deferred Tax Assets / Liabilities | 13.36 Cr | 12.79 Cr | 12.65 Cr | 10.03 Cr |
| Deferred Tax Assets | 5.28 Cr | 5.64 Cr | 5.75 Cr | 9.28 Cr |
| Deferred Tax Liability | 18.64 Cr | 18.43 Cr | 18.4 Cr | 19.31 Cr |
| Other Long Term Liabilities | 2.53 Cr | 2.54 Cr | 2.17 Cr | 2.31 Cr |
| Long Term Provisions | 34.3 Cr | 37.63 Cr | 23.07 Cr | 36.47 Cr |
| Total Non-Current Liabilities | 52.59 Cr | 54.81 Cr | 39.75 Cr | 77.99 Cr |
| Trade Payables | 362.04 Cr | 323.79 Cr | 448.27 Cr | 419 Cr |
| Sundry Creditors | 362.04 Cr | 323.79 Cr | 448.27 Cr | 419 Cr |
| Other Current Liabilities | 128.12 Cr | 136.22 Cr | 153.8 Cr | 190 Cr |
| Advances received from customers | 91.7 Cr | 97.04 Cr | 114.56 Cr | 136.1 Cr |
| Interest Accrued But Not Due | 9.25 Lk | 23,000 | 29.93 Lk | 22.01 Lk |
| Short Term Borrowings | 91.61 Cr | 45.64 Cr | 154.97 Cr | 43.15 Cr |
| Secured ST Loans repayable on Demands | 91.61 Cr | 45.64 Cr | 154.97 Cr | 43.15 Cr |
| Working Capital Loans- Sec | 91.25 Cr | 45.64 Cr | 154.97 Cr | 43.15 Cr |
| Short Term Provisions | 2.75 Cr | 2.15 Cr | 2.48 Cr | 4.11 Cr |
| Provision for Tax | 0 | 37.91 Lk | 0 | 0 |
| Total Current Liabilities | 584.52 Cr | 507.79 Cr | 759.51 Cr | 656.26 Cr |
| Total Liabilities | 1457.48 Cr | 1432.22 Cr | 1717.55 Cr | 1747.79 Cr |
| Gross Block | 336.7 Cr | 369.97 Cr | 402.11 Cr | 447.3 Cr |
| Less: Accumulated Depreciation | 97.9 Cr | 116.99 Cr | 140.38 Cr | 164.91 Cr |
| Net Block | 238.8 Cr | 252.98 Cr | 261.73 Cr | 282.39 Cr |
| Capital Work in Progress | 51.87 Cr | 85.77 Cr | 117.45 Cr | 135.4 Cr |
| Non Current Investments | 13.55 Cr | 15.55 Cr | 16.93 Cr | 19.54 Cr |
| Long Term Investment | 13.55 Cr | 15.55 Cr | 16.93 Cr | 19.54 Cr |
| Quoted | 3.62 Cr | 5.2 Cr | 6.32 Cr | 8.53 Cr |
| Unquoted | 9.93 Cr | 10.35 Cr | 10.61 Cr | 11.01 Cr |
| Long Term Loans & Advances | 59.92 Cr | 68.59 Cr | 82.26 Cr | 52.48 Cr |
| Other Non Current Assets | 48.49 Lk | 1.38 Cr | 49.02 Lk | 1.37 Cr |
| Total Non-Current Assets | 371.4 Cr | 429.48 Cr | 485.34 Cr | 499.6 Cr |
| Unquoted | 9.93 Cr | 10.35 Cr | 10.61 Cr | 11.01 Cr |
| Inventories | 660.87 Cr | 630.22 Cr | 861.72 Cr | 806.92 Cr |
| Raw Materials | 273.6 Cr | 254.05 Cr | 355.61 Cr | 276.73 Cr |
| Work-in Progress | 78.03 Cr | 60.38 Cr | 87.97 Cr | 96.42 Cr |
| Finished Goods | 275.46 Cr | 279.44 Cr | 378.2 Cr | 397.32 Cr |
| Packing Materials | 18.25 Cr | 17.14 Cr | 21.57 Cr | 18.84 Cr |
| Stores and Spare | 1.34 Cr | 1.7 Cr | 1.24 Cr | 2.02 Cr |
| Sundry Debtors | 254.59 Cr | 288.91 Cr | 296.24 Cr | 296.67 Cr |
| Debtors more than Six months | 0 | 21.43 Cr | 18.59 Cr | 32.24 Cr |
| Debtors Others | 265.6 Cr | 282.09 Cr | 292.52 Cr | 282.01 Cr |
| Cash and Bank | 83.29 Cr | 36.14 Cr | 19.69 Cr | 61.4 Cr |
| Cash in hand | 6.33 Lk | 6.13 Lk | 7.66 Lk | 11.56 Lk |
| Balances at Bank | 83.23 Cr | 36.08 Cr | 19.62 Cr | 61.29 Cr |
| Other Current Assets | 8.07 Cr | 4.19 Cr | 4.59 Cr | 6.79 Cr |
| Interest accrued and or due on loans | 2.01 Cr | 60.14 Lk | 0 | 0 |
| Prepaid Expenses | 3.72 Cr | 2.12 Cr | 3.69 Cr | 4.31 Cr |
| Short Term Loans and Advances | 79.26 Cr | 43.27 Cr | 49.96 Cr | 76.4 Cr |
| Advances recoverable in cash or in kind | 13.13 Cr | 18.94 Cr | 9.23 Cr | 13.42 Cr |
| Total Current Assets | 1086.08 Cr | 1002.74 Cr | 1232.21 Cr | 1248.19 Cr |
| Net Current Assets (Including Current Investments) | 501.57 Cr | 494.95 Cr | 472.69 Cr | 591.93 Cr |
| Total Assets | 1457.48 Cr | 1432.22 Cr | 1717.55 Cr | 1747.79 Cr |
| Contingent Liabilities | 12.86 Cr | 14.64 Cr | 14.73 Cr | 14.57 Cr |
| Total Debt | 96.27 Cr | 49.39 Cr | 159.07 Cr | 83.2 Cr |
| Book Value | 396.93 | 440.71 | 310.26 | 342.44 |
| Adjusted Book Value | 396.93 | 440.71 | 310.26 | 342.44 |
STANDALONE BALANCE SHEET FOR INSECTICIDES (INDIA) LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 20.67 Cr | 19.73 Cr | 29.6 Cr | 29.6 Cr |
| Equity - Authorised | 25 Cr | 25 Cr | 35 Cr | 35 Cr |
| Equity - Issued | 20.67 Cr | 19.73 Cr | 29.6 Cr | 29.6 Cr |
| Equity Paid Up | 20.67 Cr | 19.73 Cr | 29.6 Cr | 29.6 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 797.73 Cr | 847.48 Cr | 886.09 Cr | 981.51 Cr |
| Securities Premium | 104.1 Cr | 45.84 Cr | 35.98 Cr | 35.98 Cr |
| Profit & Loss Account Balance | 661.24 Cr | 768.04 Cr | 815.66 Cr | 909.38 Cr |
| General Reserves | 32.02 Cr | 31.08 Cr | 31.08 Cr | 31.08 Cr |
| Reserve excluding Revaluation Reserve | 797.73 Cr | 847.48 Cr | 886.09 Cr | 981.51 Cr |
| Shareholder's Funds | 818.4 Cr | 867.21 Cr | 915.69 Cr | 1011.1 Cr |
| Secured Loans | 2.4 Cr | 1.85 Cr | 1.86 Cr | 29.17 Cr |
| Term Loans - Banks | 0 | 0 | 0 | 34.42 Cr |
| Deferred Tax Assets / Liabilities | 13.36 Cr | 12.79 Cr | 12.65 Cr | 10.16 Cr |
| Deferred Tax Assets | 5.28 Cr | 5.64 Cr | 5.75 Cr | 9.15 Cr |
| Deferred Tax Liability | 18.64 Cr | 18.43 Cr | 18.4 Cr | 19.31 Cr |
| Other Long Term Liabilities | 2.53 Cr | 2.54 Cr | 2.17 Cr | 2.31 Cr |
| Long Term Provisions | 34.3 Cr | 37.63 Cr | 23.07 Cr | 36.47 Cr |
| Total Non-Current Liabilities | 52.59 Cr | 54.81 Cr | 39.75 Cr | 78.12 Cr |
| Trade Payables | 362.04 Cr | 323.79 Cr | 448.26 Cr | 418.49 Cr |
| Sundry Creditors | 362.04 Cr | 323.79 Cr | 448.26 Cr | 418.49 Cr |
| Other Current Liabilities | 128.12 Cr | 136.22 Cr | 153.77 Cr | 189.07 Cr |
| Advances received from customers | 91.7 Cr | 97.04 Cr | 114.56 Cr | 136.08 Cr |
| Interest Accrued But Not Due | 9.25 Lk | 23,000 | 29.93 Lk | 22.01 Lk |
| Short Term Borrowings | 91.61 Cr | 45.64 Cr | 154.97 Cr | 43.15 Cr |
| Secured ST Loans repayable on Demands | 91.61 Cr | 45.64 Cr | 154.97 Cr | 43.15 Cr |
| Working Capital Loans- Sec | 91.25 Cr | 45.64 Cr | 154.97 Cr | 43.15 Cr |
| Short Term Provisions | 2.75 Cr | 2.15 Cr | 2.48 Cr | 4.11 Cr |
| Provision for Tax | 0 | 37.91 Lk | 0 | 0 |
| Total Current Liabilities | 584.52 Cr | 507.79 Cr | 759.48 Cr | 654.82 Cr |
| Total Liabilities | 1455.5 Cr | 1429.82 Cr | 1714.92 Cr | 1744.05 Cr |
| Gross Block | 336.7 Cr | 369.97 Cr | 402.11 Cr | 447.11 Cr |
| Less: Accumulated Depreciation | 97.9 Cr | 116.99 Cr | 140.38 Cr | 164.91 Cr |
| Net Block | 238.8 Cr | 252.98 Cr | 261.73 Cr | 282.21 Cr |
| Capital Work in Progress | 51.87 Cr | 85.77 Cr | 117.45 Cr | 134.69 Cr |
| Non Current Investments | 11.57 Cr | 13.15 Cr | 15.45 Cr | 18.59 Cr |
| Long Term Investment | 11.57 Cr | 13.15 Cr | 15.45 Cr | 18.59 Cr |
| Quoted | 3.62 Cr | 5.2 Cr | 6.32 Cr | 8.53 Cr |
| Unquoted | 7.95 Cr | 7.95 Cr | 9.13 Cr | 10.06 Cr |
| Long Term Loans & Advances | 59.92 Cr | 68.59 Cr | 82.26 Cr | 52.47 Cr |
| Other Non Current Assets | 48.49 Lk | 1.38 Cr | 49.02 Lk | 1.37 Cr |
| Total Non-Current Assets | 369.42 Cr | 427.08 Cr | 482.96 Cr | 496.85 Cr |
| Unquoted | 7.95 Cr | 7.95 Cr | 9.13 Cr | 10.06 Cr |
| Inventories | 660.87 Cr | 630.22 Cr | 861.72 Cr | 806.46 Cr |
| Raw Materials | 273.6 Cr | 254.05 Cr | 355.61 Cr | 276.27 Cr |
| Work-in Progress | 78.03 Cr | 60.38 Cr | 87.97 Cr | 96.42 Cr |
| Finished Goods | 275.46 Cr | 279.44 Cr | 378.2 Cr | 397.32 Cr |
| Packing Materials | 18.25 Cr | 17.14 Cr | 21.57 Cr | 18.84 Cr |
| Stores and Spare | 1.34 Cr | 1.7 Cr | 1.24 Cr | 2.02 Cr |
| Sundry Debtors | 254.59 Cr | 288.91 Cr | 296.24 Cr | 296.67 Cr |
| Debtors more than Six months | 0 | 21.43 Cr | 18.59 Cr | 32.24 Cr |
| Debtors Others | 265.6 Cr | 282.09 Cr | 292.52 Cr | 282.01 Cr |
| Cash and Bank | 83.29 Cr | 36.14 Cr | 19.45 Cr | 61.21 Cr |
| Cash in hand | 6.33 Lk | 6.13 Lk | 7.66 Lk | 8.45 Lk |
| Balances at Bank | 83.23 Cr | 36.08 Cr | 19.37 Cr | 61.13 Cr |
| Other Current Assets | 8.07 Cr | 4.19 Cr | 4.59 Cr | 6.79 Cr |
| Interest accrued and or due on loans | 2.01 Cr | 60.14 Lk | 0 | 0 |
| Prepaid Expenses | 3.72 Cr | 2.12 Cr | 3.69 Cr | 4.31 Cr |
| Short Term Loans and Advances | 79.26 Cr | 43.27 Cr | 49.95 Cr | 76.07 Cr |
| Advances recoverable in cash or in kind | 13.13 Cr | 18.94 Cr | 9.22 Cr | 13.42 Cr |
| Total Current Assets | 1086.08 Cr | 1002.74 Cr | 1231.95 Cr | 1247.2 Cr |
| Net Current Assets (Including Current Investments) | 501.57 Cr | 494.95 Cr | 472.47 Cr | 592.38 Cr |
| Total Assets | 1455.5 Cr | 1429.82 Cr | 1714.92 Cr | 1744.05 Cr |
| Contingent Liabilities | 12.86 Cr | 14.64 Cr | 14.73 Cr | 14.57 Cr |
| Total Debt | 96.27 Cr | 49.39 Cr | 159.07 Cr | 83.2 Cr |
| Book Value | 395.98 | 439.5 | 309.38 | 341.62 |
| Adjusted Book Value | 395.98 | 439.5 | 309.38 | 341.62 |
FINANCIAL RATIOS (CONSOLIDATED) FOR INSECTICIDES (INDIA) LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 45.43 | 54.44 | 21.36 | 34.59 |
| CEPS(Rs) | 57.14 | 67.8 | 30.18 | 44.47 |
| DPS(Rs) | 2 | 3 | 3 | 3 |
| Book NAV/Share(Rs) | 396.93 | 440.71 | 310.26 | 342.44 |
| Tax Rate(%) | 21.51 | 24.01 | 24.6 | 22.56 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 9.6 | 10.28 | 6.14 | 7.4 |
| EBIT Margin(%) | 7.92 | 8.96 | 4.9 | 6.52 |
| Pre Tax Margin(%) | 7.5 | 8.56 | 4.22 | 6.02 |
| PAT Margin (%) | 5.89 | 6.51 | 3.18 | 4.66 |
| Cash Profit Margin (%) | 7.44 | 8.1 | 4.5 | 6 |
| Performance Ratios | ||||
| ROA(%) | 6.74 | 7.44 | 4.01 | 5.91 |
| ROE(%) | 12.04 | 12.71 | 7.07 | 10.6 |
| ROCE(%) | 13.69 | 16.13 | 9.75 | 13.16 |
| Asset Turnover(x) | 1.14 | 1.14 | 1.26 | 1.27 |
| Sales/Fixed Asset(x) | 4.88 | 4.67 | 5.14 | 5.17 |
| Working Capital/Sales(x) | 3.16 | 3.34 | 4.2 | 3.71 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 0.2 | 0.21 | 0.19 | 0.19 |
| Receivable days | 66.07 | 60.07 | 53.79 | 49.29 |
| Inventory Days | 135.75 | 142.71 | 137.14 | 138.72 |
| Payable days | 86.18 | 124.25 | 110.52 | 118.49 |
| Valuation Parameters | ||||
| PER(x) | 10.43 | 11.27 | 21.88 | 14.13 |
| PCE(x) | 8.29 | 9.05 | 15.48 | 10.99 |
| Price/Book(x) | 1.19 | 1.39 | 1.51 | 1.43 |
| Yield(%) | 0.42 | 0.49 | 0.64 | 0.61 |
| EV/Net Sales(x) | 0.7 | 0.81 | 0.85 | 0.75 |
| EV/Core EBITDA(x) | 6.2 | 7.04 | 12.36 | 8.54 |
| EV/EBIT(x) | 7.9 | 8.27 | 15.65 | 10.26 |
| EV/CE(x) | 0.68 | 0.85 | 0.89 | 1.34 |
| M Cap / Sales | 0.69 | 0.81 | 0.77 | 0.74 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 4.18 | 5.9 | 19.77 | 9.16 |
| Core EBITDA Growth(%) | 1.03 | 8.68 | -29.2 | 39.68 |
| EBIT Growth(%) | -6.45 | 17.32 | -34.27 | 47.08 |
| PAT Growth(%) | 8.59 | 14.4 | -41.16 | 61.94 |
| EPS Growth(%) | 8.04 | 19.83 | -60.77 | 61.94 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.12 | 0.06 | 0.17 | 0.08 |
| Current Ratio(x) | 1.86 | 1.97 | 1.62 | 1.9 |
| Quick Ratio(x) | 0.73 | 0.73 | 0.49 | 0.67 |
| Interest Cover(x) | 18.9 | 22.31 | 7.23 | 13.14 |
| Total Debt/Mcap(x) | 0.1 | 0.04 | 0.12 | 0.06 |
FINANCIAL RATIOS (STANDALONE) FOR INSECTICIDES (INDIA) LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 45.21 | 54.24 | 21.28 | 34.67 |
| CEPS(Rs) | 57.14 | 67.59 | 30.1 | 44.56 |
| DPS(Rs) | 2 | 3 | 3 | 3 |
| Book NAV/Share(Rs) | 395.98 | 439.5 | 309.38 | 341.62 |
| Tax Rate(%) | 21.51 | 24.08 | 24.66 | 22.59 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 9.6 | 10.28 | 6.14 | 7.43 |
| EBIT Margin(%) | 7.92 | 8.94 | 4.89 | 6.54 |
| Pre Tax Margin(%) | 7.5 | 8.54 | 4.21 | 6.04 |
| PAT Margin (%) | 5.89 | 6.48 | 3.17 | 4.67 |
| Cash Profit Margin (%) | 7.44 | 8.08 | 4.49 | 6.01 |
| Performance Ratios | ||||
| ROA(%) | 6.74 | 7.42 | 4.01 | 5.93 |
| ROE(%) | 12.07 | 12.7 | 7.07 | 10.65 |
| ROCE(%) | 13.72 | 16.12 | 9.75 | 13.23 |
| Asset Turnover(x) | 1.15 | 1.14 | 1.26 | 1.27 |
| Sales/Fixed Asset(x) | 4.88 | 4.67 | 5.14 | 5.17 |
| Working Capital/Sales(x) | 3.16 | 3.34 | 4.2 | 3.71 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 0.2 | 0.21 | 0.19 | 0.19 |
| Receivable days | 66.07 | 60.07 | 53.79 | 49.29 |
| Inventory Days | 135.75 | 142.71 | 137.14 | 138.68 |
| Payable days | 86.18 | 124.25 | 110.51 | 118.41 |
| Valuation Parameters | ||||
| PER(x) | 10.48 | 11.32 | 21.95 | 14.1 |
| PCE(x) | 8.29 | 9.08 | 15.52 | 10.97 |
| Price/Book(x) | 1.2 | 1.4 | 1.51 | 1.43 |
| Yield(%) | 0.42 | 0.49 | 0.64 | 0.61 |
| EV/Net Sales(x) | 0.7 | 0.81 | 0.85 | 0.75 |
| EV/Core EBITDA(x) | 6.2 | 7.04 | 12.36 | 8.5 |
| EV/EBIT(x) | 7.9 | 8.29 | 15.69 | 10.24 |
| EV/CE(x) | 0.68 | 0.86 | 0.89 | 1.34 |
| M Cap / Sales | 0.69 | 0.81 | 0.77 | 0.74 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 4.18 | 5.9 | 19.77 | 9.16 |
| Core EBITDA Growth(%) | 1.03 | 8.68 | -29.2 | 40.23 |
| EBIT Growth(%) | -6.45 | 17.44 | -34.24 | 47.81 |
| PAT Growth(%) | 8.59 | 14.54 | -41.14 | 62.93 |
| EPS Growth(%) | 8.59 | 19.98 | -60.76 | 62.93 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.12 | 0.06 | 0.17 | 0.08 |
| Current Ratio(x) | 1.86 | 1.97 | 1.62 | 1.9 |
| Quick Ratio(x) | 0.73 | 0.73 | 0.49 | 0.67 |
| Interest Cover(x) | 18.9 | 22.25 | 7.22 | 13.18 |
| Total Debt/Mcap(x) | 0.1 | 0.04 | 0.12 | 0.06 |
SHARE HOLDING PATTERN FOR INSECTICIDES (INDIA) LIMITED
| Date | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters % | 72.16 | 72.16 | 72.16 | 72.16 | 72.16 | 72.16 | 72.16 | 72.16 | 72.16 | 72.16 |
| FII % | 5.42 | 6.66 | 6.32 | 6.27 | 6.46 | 6.01 | 5.19 | 4.41 | 4.31 | 4.36 |
| DII % | 0.12 | 0.12 | 0.00 | 0.00 | 0.14 | 0.06 | 0.07 | 0.33 | 0.35 | 0.29 |
| Public % | 13.51 | 10.20 | 10.58 | 10.63 | 10.62 | 11.30 | 13.30 | 14.31 | 14.39 | 14.41 |
PEER COMPARISON FOR INSECTICIDES (INDIA) LIMITED
CORPORATE ACTIONS FOR INSECTICIDES (INDIA)
| Exchange Date | Purpose | Book Closure Dates |
|---|---|---|
| BSE 27-Sep-2024 | Board Meeting - Quarterly Results | 11-Nov-2024 |
| BSE 27-Aug-2024 | Board Meeting - Buy Back of Shares | 30-Aug-2024 |
| BSE 23-Aug-2024 | Dividend - Interim Dividend | |
| BSE 22-Jul-2024 | Board Meeting - Quarterly Results | 09-Aug-2024 |
| BSE 10-Apr-2024 | Board Meeting - Quarterly Results & Audited Results | 28-May-2024 |
| BSE 29-Dec-2023 | Board Meeting - Quarterly Results | 05-Feb-2024 |
| BSE 10-Nov-2023 | Dividend - Interim Dividend | |
| BSE 29-Sep-2023 | Board Meeting - Quarterly Results & Interim Dividend | 02-Nov-2023 |
| BSE 02-Aug-2023 | SAST - This is to inform that the Company has acquired the industrial site located within the Industrial Area of Sotanala, Alwar, Rajasthan | |
| BSE 18-Jul-2023 | Board Meeting - Quarterly Results | 10-Aug-2023 |
| BSE 17-May-2023 | Board Meeting - Audited Results | 30-May-2023 |
| BSE 24-Feb-2023 | Dividend - Interim Dividend | |
| BSE 23-Jan-2023 | Board Meeting - Quarterly Results | 13-Feb-2023 |
| BSE 18-Oct-2022 | Board Meeting - Quarterly Results | 07-Nov-2022 |
| BSE 02-Sep-2022 | Book Closure - Rs.3.0000 per share(30%)Final Dividend & A.G.M. | 17-Sep-2022 20-Sep-2022 |
| BSE 02-Sep-2022 | AGM - Rs.3.0000 per share(30%)Final Dividend & A.G.M. | 20-Sep-2022 20-Sep-2022 |
| BSE 22-Aug-2022 | Bonus issue - Bonus Issue Inter alia considered and approved the following: 1. Appointment of Director(s): a) Appointment of Mr. Anil Kumar Bhatia as an Independent Director: Approved appointment of Mr. Anil Kumar Bhatia (DIN: 09707921) as an Independent Director w.e.f. August 20, 2022 for a period of five years, not liable to retire by rotation, subject to approval of the shareholders. b) Appointment of Mr. An... | 20-Aug-2022 |
| BSE 12-Aug-2022 | Board Meeting - Bonus issue | 20-Aug-2022 |
| BSE 12-Aug-2022 | Bonus issue - Bonus issue | 20-Aug-2022 |
| BSE 01-Aug-2022 | Board Meeting - Quarterly Results | 12-Aug-2022 |
| BSE 20-Jul-2022 | SAST - Intimation of the Incorporation of Wholly Owned Subsidiary (WOS) of the Company. | |
| BSE 26-May-2022 | Dividend - Rs.3.0000 per share(30%)Final Dividend | |
| BSE 09-May-2022 | Board Meeting - Audited Results | 26-May-2022 |
| BSE 20-Jan-2022 | Board Meeting - Quarterly Results | 10-Feb-2022 |
| BSE 25-Oct-2021 | Board Meeting - Quarterly Results | 12-Nov-2021 |
CORPORATE ANNOUNCEMENTS FOR INSECTICIDES (INDIA)
| Exchange Date | Category File | Description |
|---|---|---|
| BSE 11-Oct-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 we enclose herewith a copy of the Certificate received from Alankit Assignments Limited the Registrar and Share Transfer Agent of the Company for the quarter ended September 30 2024 |
| BSE 10-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Closure of Buy Back Buyback of Equity Shares - Completion of extinguishment/destruction of a total of 5 00 000 Equity Shares |
| BSE 04-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Product Launch |
| BSE 01-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Enclosed is the copy of Post Offer Public Announcement published in the newspapers on Tuesday October 01 2024: |
| BSE 27-Sep-2024 | Intimation FILE | Closure of Trading Window Pursuant to the Companys Code of Conduct for Prohibition of Insider trading in dealing with securities of the Company and the relevant provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time it is informed that the Trading Window for dealing in securities of Insecticides (India) Limited by Designated Persons and their immediate relatives shall remain closed from October 01 2024 till the end of 48 hours after the declaration of financial results for the quarter ended September 30 2024. |
| BSE 27-Sep-2024 | Intimation FILE | Board Meeting Intimation for Prior Intimation Of Board Meeting INSECTICIDES (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 this is to inform that the Meeting of Board of Directors of the Company is scheduled to be held on Monday 11th day of November 2024 inter alia to consider and approve the Unaudited Standalone and Consolidated financial results for the Quarter and half year ended September 30 2024 |
| BSE 17-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Enclosed is the copy of Offer Opening Advertisement cum Corrigendum to the Letter of offer. |
| BSE 16-Sep-2024 | General Announcements FILE | Draft Of The Offer Opening Advertisement Cum Corrigendum To The Letter Of Offer Pertaining To The Ongoing Buyback. Draft of the offer opening advertisement cum corrigendum to the Letter of Offer pertaining to the ongoing Buyback. |
| BSE 13-Sep-2024 | General Announcements FILE | Letter Of Offer Pertaining To The Buyback Of The Equity Shares By The Company Letter of Offer pertaining to the Buyback of the Equity Shares by the Company |
| BSE 13-Sep-2024 | General FILE | Letter of Offer Sundae Capital Advisors Pvt. Ltd. ("Manager to the Buyback") has submitted to BSE a copy of Letter of Offer for the attention of Equity Shareholders / Beneficial Owners of the equity shares of Insecticides (India) Ltd ("the Company"). |
| BSE 03-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Enclosed is the copy of public announcement pertaining to the Buyback of equity shares. |
| BSE 03-Sep-2024 | General FILE | Public Announcement - Buyback Offer Sundae Capital Advisors Pvt. Ltd. ("Manager to the Buyback") has submitted to BSE a copy of Public Announcement for the attention of Equity Shareholders / Beneficial Owners of the equity shares of Insecticides (India) Ltd ("the Company") for the Buyback of Equity Shares through a Tender Offer Route ("Tender Offer") using Stock Exchange Mechanism as prescribed under the Securities and Exchange Board of India (Buyback of Securities) Regulations 2018 as amended from time to time. |
| BSE 30-Aug-2024 | Intimation FILE | Corporate Action-Intimation of Buy back we wish to inform you that the Board of Directors at its meeting held today i.e. on August 30 2024 has inter alia approved the proposal to Buyback its own fully paid up Equity Shares of Rs. 10/- each (Equity Shares) from the equity shareholders of the Company as on Record Date for upto 5 00 000 fully paid-up Equity Shares (being 1.69% of the total paid up equity capital of the Company) at a price of Rs. 1 000/- (Rupees One Thousand only) per equity share (Buyback Offer Price) for an aggregate amount notexceeding Rs. 50 Crore (Rupees Fifty Crore only) (Offer Size) (being less than 10% of the Paid-up Equity Capital and free reserves as on March 31 2024) on a proportionate basis through the "Tender Offer" route |
| BSE 30-Aug-2024 | Intimation FILE | Corporate Action-Record Date For Buy Back The Board has decided Wednesday September 11 2024 as the Record Date for the purpose of determining the entitlement and the names of equity shareholders who are eligible to participate in the proposed Buyback Offer. |
| BSE 30-Aug-2024 | Outcome FILE | Board Meeting Outcome for Outcome Of The Board Meeting - Proposal Of Buy Back Of Equity Shares we wish to inform you that the Board of Directors at its meeting held today i.e. on August 30 2024 has inter alia approved the proposal to Buyback its own fully paid up Equity Shares of Rs. 10/- each (Equity Shares) from the equityshareholders of the Company as on Record Date for upto 5 00 000 fully paid-up Equity Shares (being 1.69% of the total paid up equity capital of the Company) at a price of Rs. 1 000/- (RupeesOne Thousand only) per equity share (Buyback Offer Price) for an aggregate amount not exceeding Rs. 50 Crore (Rupees Fifty Crore only) (Offer Size) (being less than 10% of the Paid-up Equity Capital and free reserves as on March 31 2024) on a proportionate basis through the "Tender Offer" route |
| BSE 27-Aug-2024 | Intimation FILE | Closure of Trading Window It is informed that the Trading Window for dealing in securities of Insecticides (India) Limited will be closed till the end of 48 hours after the announcement of buy-back if approved by the Board of Directors in their meeting held on August 30 2024. |
| BSE 27-Aug-2024 | Intimation FILE | Board Meeting Intimation for Intimation Of Board Meeting For Consideration Of Buy-Back Of Equity Shares Of The Company Under Regulation 29(1)(B) Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations 2015 INSECTICIDES (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/08/2024 inter alia to consider and approve the proposal for Buy-back of fully paid-up equity shares of the Company through Tender Offer route up to such amount of the aggregate of Companys paid up equity share capital and free reserves as the Board may decide in accordance with Section 68 69 and 70 of the Companies Act 2013 and the SEBI(Buy-back of Securities) Regulations 2018 |
| BSE 16-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Earnings Call Transcript Please find enclosed the copy of Transcript of the Earning Conference Call held on August 09 2024 in connection with Unaudited Standalone and Consolidated results of the Company for the Quarter ended June 30 2024 |
| BSE 14-Aug-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Outcome of AGM Pursuant to Regulation 44(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 Please find the enclosed consolidated Voting Results of 27th Annual General Meeting along with Scrutinizers report. |
| BSE 14-Aug-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Pursuant to Regulation 44(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 Please find the enclosed Voting Results of 27th Annual General Meeting held on August 12 2024 along with of Scrutinizers Report. |
| BSE 12-Aug-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Outcome of AGM Please find enclosed summary of proceedings of the 27th Annual General Meeting (AGM) of the Company. |
| BSE 10-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Please find enclosed the extracts of Newspaper advertisement wherein Unaudited Financial Results for the Quarter ended June 30 2024 have ben published. |
| BSE 09-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Link for the audio recording of investor call for quarter ended on June 30 2024. |
| BSE 09-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Change in Management Changes in Senior Management Personnel of the Company - Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) |
| BSE 09-Aug-2024 | General Announcements FILE | The Board Of Directors Approves The Windup Or Dissolution Of The 'IIL Overseas DMCC' Dubai A Wholly Owned Subsidiary Of The Company At Dubai UAE The Board of Directors approves the windup or dissolution of the IIL Overseas DMCC Dubai a wholly owned subsidiary of the Company at Dubai United Arab Emirates (UAE) according to the Registrar of Companies of the Dubai Multi Commodities Centre Authority (DMCCA). |
| BSE 09-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Change in Management On the recommendation of Nomination Remuneration and Ethics Committee the Board of Directors approved the appointment of Mr. Dushyant Sood as a Chief Marketing Officer(CMO) of the Company w.e.f August 09 2024. |
| BSE 09-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Investor Presentation Please find enclosed the Q1 of FY2024-25 Investor / Earning presentation on the first quarter ended June 30 2024. |
| BSE 09-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Date of payment of Dividend The Board of Directors of the Insecticides (India) Limited/the Company (Board) at their meeting held today i.e August 09 approved the an Interim Dividend of Rs. 2.00/- per equity shares [20%] of face value of Rs. 10/- each for financial year 2024-2025. The Interim Dividend will be paid on or from August 28 2024. |
| BSE 09-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Dividend Updates The Board of Directors of the Insecticides (India) Limited/the Company (Board) at their meeting held today i.e August 09 approved the an Interim Dividend of Rs. 2.00/- per equity shares [20%] of face value of Rs. 10/- each for financial year 2024-2025. |
| BSE 09-Aug-2024 | Outcome FILE | Corporate Action-Board approves Dividend The Board of Directors of the Insecticides (India) Limited/the Company (Board) at their meeting held today i.e August 09 approved the an Interim Dividend of Rs. 2.00/- per equity shares [20%] of face value of Rs. 10/- each for financial year 2024-2025. |
INSIDER TRADING FOR INSECTICIDES (INDIA)
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 30-Sep-2024 30-Sep-2024 | Buy Back | 64,388 @ 0.00 (0.03 %) | Sanskar Aggarwal |
| BSE 30-Sep-2024 30-Sep-2024 | Buy Back | 7,861 @ 0.00 (0.00 %) | ISEC Organic Ltd |
| BSE 30-Sep-2024 30-Sep-2024 | Buy Back | 53,640 @ 0.00 (0.03 %) | Hari Chand Aggarwal |
| BSE 30-Sep-2024 30-Sep-2024 | Buy Back | 52,191 @ 0.00 (0.00 %) | Pushpa Aggarwal |
| BSE 30-Sep-2024 30-Sep-2024 | Buy Back | 69,637 @ 0.00 (0.03 %) | Nikunj Aggarwal |
| BSE 30-Sep-2024 30-Sep-2024 | Buy Back | 72,672 @ 0.00 (0.03 %) | Rajesh Kumar Aggarwal |
| BSE 26-Aug-2024 26-Aug-2024 | Sell Inter-Se Transfer | 20,000 @ 0.00 (0.07 %) | ISEC Organics Ltd |
| BSE 26-Aug-2024 26-Aug-2024 | Buy Inter-Se Transfer | 20,000 @ 0.00 (0.06 %) | Nikunj Aggarwal |
| BSE 29-Dec-2023 29-Dec-2023 | Buy Gift | 2,241,000 @ 0.00 (7.57 %) | Hari Chand Aggarwal |
| BSE 29-Dec-2023 29-Dec-2023 | Sell Gift | 2,241,000 @ 0.00 (0.00 %) | H C Aggarwal HUF |
| BSE 29-Dec-2023 29-Dec-2023 | Sell Gift | 2,929,500 @ 0.00 (0.00 %) | Rajesh Aggarwal HUF |
| BSE 29-Dec-2023 29-Dec-2023 | Buy Gift | 2,929,500 @ 0.00 (9.90 %) | Rajesh Kumar Aggarwal |
BULK BLOCK DEALS FOR INSECTICIDES (INDIA) LIMITED
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 13-May-2022 | Sell BULK | 117,740 @ 715.02 | O J FINANCIAL SERVICES LTD. |
DIVIDEND BY INSECTICIDES (INDIA) LIMITED
| Ex Dividend Date | Dividend Type | Dividend |
|---|---|---|
| 23-Aug-2024 | INTERIM DIVIDEND | 2 |
| 10-Nov-2023 | INTERIM DIVIDEND | 3 |
| 24-Feb-2023 | INTERIM DIVIDEND | 3 |
| 15-Sep-2022 | DIVIDEND | 3 |
| 19-Nov-2020 | INTERIM DIVIDEND | 2 |
SPLIT / BONUS BY INSECTICIDES (INDIA) LIMITED
| Ex Date | Type | Detail |
|---|---|---|
| 30-Sep-2022 | BONUS | 1:2 |
Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed